depression Archives -

J&J seeks wider use of its Spravato antidepressant in US

https://pharmaphorum.com/news/jj-seeks-wider-use-of-its-spravato-antidepressant-in-us/

J&J’s Spravato for depression ‘should be much cheaper’

https://pharmaphorum.com/news/jjs-spravato-for-depression-should-be-much-cheaper/

Abilify MyCite and innovating in digital health

https://pharmaphorum.com/views-analysis-digital/abilify-mycite-and-innovating-in-digital-health/

FDA approves Janssen’s ketamine-based nasal antidepressant

https://pharmaphorum.com/news/fda-approves-janssens-ketamine-based-nasal-antidepressant/

FDA panel backs J&J’s potential depression blockbuster

https://pharmaphorum.com/news/fda-panel-backs-jjs-potential-depression-blockbuster/

https://pharmaphorum.com/news/nice-backs-digital-cbt-for-youngsters-with-depression/

Otsuka funds prescription therapy app for depression

https://pharmaphorum.com/news/otsuka-funds-app-depression/

J&J preps for FDA panel grilling over depression drug

https://pharmaphorum.com/news/janssen-preps-for-fda-panel-grilling-esketamine/

J&J files esketamine nasal spray antidepressant in US

https://pharmaphorum.com/news/jj-files-esketamine-nasal-spray-antidepressant-in-us/

Search